A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome.
| Image |  |
|---|---|
| Description | scientific article published on 24 February 2015 |
| Author/s |
author: James H Rudd Venkatesh Mani Tilmann M Brotz Zahi A Fayad Jean-Claude Tardif |
| Publication date | February 24, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |